Free Trial
NASDAQ:SOPH

SOPHiA GENETICS (SOPH) Stock Price, News & Analysis

SOPHiA GENETICS logo
$3.43 -0.06 (-1.72%)
Closing price 07/22/2025 04:00 PM Eastern
Extended Trading
$3.41 -0.02 (-0.58%)
As of 07:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About SOPHiA GENETICS Stock (NASDAQ:SOPH)

Key Stats

Today's Range
$3.43
$3.72
50-Day Range
$2.85
$3.75
52-Week Range
$2.58
$4.92
Volume
26,351 shs
Average Volume
58,958 shs
Market Capitalization
$228.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Moderate Buy

Company Overview

SOPHiA GENETICS Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
43rd Percentile Overall Score

SOPH MarketRank™: 

SOPHiA GENETICS scored higher than 43% of companies evaluated by MarketBeat, and ranked 561st out of 917 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    SOPHiA GENETICS has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    SOPHiA GENETICS has received no research coverage in the past 90 days.

  • Read more about SOPHiA GENETICS's stock forecast and price target.
  • Earnings Growth

    Earnings for SOPHiA GENETICS are expected to grow in the coming year, from ($0.96) to ($0.81) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of SOPHiA GENETICS is -3.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of SOPHiA GENETICS is -3.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    SOPHiA GENETICS has a P/B Ratio of 2.32. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about SOPHiA GENETICS's valuation and earnings.
  • Percentage of Shares Shorted

    0.03% of the float of SOPHiA GENETICS has been sold short.
  • Short Interest Ratio / Days to Cover

    SOPHiA GENETICS has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in SOPHiA GENETICS has recently decreased by 16.23%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    SOPHiA GENETICS does not currently pay a dividend.

  • Dividend Growth

    SOPHiA GENETICS does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.03% of the float of SOPHiA GENETICS has been sold short.
  • Short Interest Ratio / Days to Cover

    SOPHiA GENETICS has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in SOPHiA GENETICS has recently decreased by 16.23%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for SOPHiA GENETICS this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    1 people have added SOPHiA GENETICS to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, SOPHiA GENETICS insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.88% of the stock of SOPHiA GENETICS is held by insiders.

  • Percentage Held by Institutions

    Only 31.59% of the stock of SOPHiA GENETICS is held by institutions.

  • Read more about SOPHiA GENETICS's insider trading history.
Receive SOPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SOPHiA GENETICS and its competitors with MarketBeat's FREE daily newsletter.

SOPH Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

SOPH Stock Analysis - Frequently Asked Questions

SOPHiA GENETICS's stock was trading at $3.07 on January 1st, 2025. Since then, SOPH shares have increased by 11.7% and is now trading at $3.43.

SOPHiA GENETICS SA (NASDAQ:SOPH) issued its quarterly earnings data on Tuesday, May, 6th. The company reported ($0.26) EPS for the quarter, missing the consensus estimate of ($0.21) by $0.05. The company earned $17.78 million during the quarter, compared to analyst estimates of $16.76 million. SOPHiA GENETICS had a negative net margin of 98.51% and a negative trailing twelve-month return on equity of 63.47%.
Read the conference call transcript
.

SOPHiA GENETICS (SOPH) raised $234 million in an initial public offering on Friday, July 23rd 2021. The company issued 13,000,000 shares at a price of $17.00-$19.00 per share.

SOPHiA GENETICS's top institutional shareholders include Silverberg Bernstein Capital Management LLC (0.07%) and Ridgewood Investments LLC (0.05%).

Shares of SOPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SOPHiA GENETICS investors own include Occidental Petroleum (OXY), PayPal (PYPL), Chesapeake Energy (CHK), Cheniere Energy (LNG), Rocket Pharmaceuticals (RCKT), AbCellera Biologics (ABCL) and Farmers & Merchants Bancorp (FMAO).

Company Calendar

Last Earnings
5/06/2025
Today
7/23/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SOPH
CIK
1840706
Fax
N/A
Employees
520
Year Founded
N/A

Price Target and Rating

High Price Target
$11.00
Low Price Target
$5.00
Potential Upside/Downside
+104.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.00)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$62.49 million
Net Margins
-98.51%
Pretax Margin
-96.41%
Return on Equity
-63.47%
Return on Assets
-40.06%

Debt

Debt-to-Equity Ratio
0.16
Current Ratio
3.11
Quick Ratio
2.94

Sales & Book Value

Annual Sales
$65.17 million
Price / Sales
3.51
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.48 per share
Price / Book
2.32

Miscellaneous

Outstanding Shares
66,690,000
Free Float
63,433,000
Market Cap
$228.75 million
Optionable
Not Optionable
Beta
1.00
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:SOPH) was last updated on 7/23/2025 by MarketBeat.com Staff
From Our Partners